Loading...
Inventiva Community
ENXTPA:IVA Community- 2 Narratives written by author
- 0 Comments on narratives written by author
- 8 Fair Values set on narratives written by author
Community Investing Ideas
Analysts Boost Inventiva Price Target Amid Optimism for MASH Market and Pipeline Progress
Key Takeaways Strategic focus on lanifibranor development, cutting other activities, and reducing workforce may improve net margins through operational efficiency. Key partnerships in Asia and financial strength ensure market penetration and support sustained investment, boosting future earnings potential.Read more
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
€7.95
57.4% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
118.21% p.a.
Profit Margin
41.15%
Future PE
22.61x
Share price in 2028
€5.37
Global Aging Trends Will Spark Demand For MASH Treatments
Key Takeaways Leadership in multimodal metabolic therapies and innovative clinical positioning could drive outsized revenue and expand Inventiva's market reach over time. Decisive restructuring and strategic partnerships enhance margins and acquisition appeal, positioning the company for industry-leading financial performance and transformative growth opportunities.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
€10
66.1% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
188.17% p.a.
Profit Margin
64.78%
Future PE
7.65x
Share price in 2028
€17.48